Charles E. Barr, MD, MPH, Appointed Chief Science Officer of Biologics and Biosimilars Collective Intelligence Consortium

ALEXANDRIA, Va., Dec. 6, 2017 /PRNewswire-USNewswire/ — The Biologics and Biosimilars Collective Intelligence Consortium (BBCIC) is pleased to announce that Charles Barr, M.D., MPH, has been appointed Chief Science Officer (CSO). The BBCIC was convened by the Academy of Managed Care…